Real-time enrollment status for this infant leukemia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:37 AM UTC
| NCT Number | NCT06317662 |
| Recruiting Status | Recruiting |
| Condition | Infant Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 153 participants |
| Active Locations | 112 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 13, 2026 (4 days ago) |
As of July 17, 2026: Clinical trial NCT06317662 is currently recruiting participants. This phase2 study for infant leukemia is actively seeking new participants at 112 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06317662 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 112 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06317662 was last updated 4 days ago (July 13, 2026). HelloStudys verifies this status automatically.